Latest Strategic Reviews News

Codeifai Limited reports a robust 141% increase in Q1 2025 cash receipts, driven by its revamped Digital First Engagement First strategy and the expanding ConnectQR SaaS platform. Despite rising costs, the company maintains strong margins and is strategically reviewing its Material Science division.

Resource Base Limited has bolstered its portfolio with two new tenements in the Gawler Craton, South Australia, while managing a modest cash reserve of $0.93 million and raising $45,300 through a loyalty option offer.

IPB Petroleum Limited has secured a crucial two-year extension on its WA-424-P permit in the Browse Basin, enabling continued exploration and development of its Gwydion asset while maintaining a solid cash position of AUD 1.487 million.

Diablo Resources has identified six promising copper mineralisation targets at its newly acquired Phoenix Copper Project near the Lisbon Valley Mine, backed by a $576,800 capital raise to fund upcoming drilling in 2025.

Falcon Metals confirms robust mineralogical quality at its Farrelly Mineral Sands deposit and reveals promising gold structures at Pyramid Hill, underpinning a strategic exploration push in Victoria.

MedAdvisor Solutions reported a challenging third quarter with steep revenue declines, driven by delayed program launches and US sales underperformance, but is executing a strategic overhaul and cost-cutting measures to position for a rebound and 15% revenue growth in FY26.

MedAdvisor Limited reports a steep decline in 3Q FY25 revenue, driven by US market challenges, while accelerating cost-cutting and reaffirming full-year guidance.

Linius Technologies embarks on a strategic transformation under CEO Ben Taverner, focusing on operational restructuring, AI-enhanced SaaS products, and market expansion beyond sports to achieve breakeven by June 2026.

Althea Group Holdings reported $5.02 million in Q3 FY25 receipts, driven by strong growth at Peak Canada and the launch of Peak USA, while its pharmaceutical cannabis division faces steep revenue declines prompting strategic review.

AnteoTech Ltd reports progress in advanced battery and life sciences technologies alongside a strategic review and leadership changes amid challenging EV market conditions.

Percheron Therapeutics has discontinued its ATL1103 program and curtailed investment in ATL1102 following underwhelming trial results, while advancing talks to in-license new rare disease therapies and extending its cash runway into FY2027.

Flynn Gold Limited reported significant progress in its Tasmanian projects during the March 2025 quarter, highlighted by ongoing diamond drilling at Golden Ridge and discovery of new high-grade gold and silver-lead-zinc targets. The company secured $2.6 million in fresh capital to fund accelerated exploration.